UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000052001
Receipt number R000059353
Scientific Title Effects of ankle-foot orthosis with functional electrical stimulation intervention on gait disturbance in subacute hemiplegia patients -a series of single case design-
Date of disclosure of the study information 2023/08/31
Last modified on 2025/02/22 23:54:29

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effects of ankle-foot orthosis with functional electrical stimulation intervention on gait disturbance in subacute hemiplegia
patients -a series of single case design-

Acronym

Effects of ankle-foot orthosis with functional electrical stimulation intervention on gait disturbance

Scientific Title

Effects of ankle-foot orthosis with functional electrical stimulation intervention on gait disturbance in subacute hemiplegia
patients -a series of single case design-

Scientific Title:Acronym

Effects of ankle-foot orthosis with functional electrical stimulation intervention on gait disturbance

Region

Japan


Condition

Condition

Stroke

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To determine the efficacy of ankle-foot orthosis with functional electrical stimulation intervention for gait disturbance in stroke hemiplegia with inadequate ankle dorsiflexion angle while walking.
In addition, a single case design should be implemented for multiple cases to verify the effectiveness of the treatment.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

10m walk test(maximum walking speed)

Key secondary outcomes

ankle joint dorsiflexion angle during gait
EMG using electromyography(tibialis anterior,gastrocnemius)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

For single cases, interventions will begin with gait practice with ankle-foot orthosis (period A1), transition to gait practice with ankle-foot orthosis plus functional electrical stimulation (period B1), return to gait practice with ankle-foot orthosis (period A2), and transition to gait practice with ankle-foot orthosis plus functional electrical stimulation (period B2). Each phase will consist of seven interventions, one per day

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

18 years-old <=

Age-upper limit

85 years-old >

Gender

Male and Female

Key inclusion criteria

Stroke hemiplegic patients admitted to the Kaifukukirehabilitation ward of Medical Corporation Juryo Kumamoto Kinoh Hospital who meet the following conditions
1)Patients with insufficient ankle dorsiflexion angle during gait (dorsiflexion angle less than 0 degree during gait)
2)Patients receiving orthosis therapy for 1)
3)First seizure cerebral infarction or cerebral hemorrhage
4)More than 1 month to 6 months after onset
5) Patients whose Functional Ambulation Categories (FAC) are
2 (light assistance) or 3 (supervised)
6)No obvious paralytic symptoms or motor deficits on the nonparalytic side
7)Patients who can obtain ankle dorsiflexion movement using functional electrical stimulation
(Patients without peripheral neuropathy such as common peroneal nerve palsy)

Key exclusion criteria

1)Patients contraindicated to functional electrical stimulation(For example patients with a cardiac pacemaker , those with a history of epileptic seizures or those who are expected to have seizures, Persons with metal implants )
2)Patients with cardiovascular disease and at risk for exercise
3)Patients whose ankle dorsiflexion angle has not reached 0 degree with orthokinetic exercise
4)Patients who are unable to understand the study description or cannot appeal for discontinuation of the study on their own in the event of abnormality.
(For example mini mental state examination score: MMSE less than 21 points)
5)Patients under 18 years of age or over 85 years of age
6)Patients with severe sensory disturbance or marked muscle tone (modified Ashworth scale: MAS 3 or higher)
7)Patients who have difficulty understanding instructions or walking independently due to the effects of attention disorders or other cognitive dysfunction

Target sample size

6


Research contact person

Name of lead principal investigator

1st name Katsuhiko
Middle name
Last name Sannomiya

Organization

Medical Corporation Juryo Kumamoto Kinoh Hospital

Division name

Department of Comprehensive Rehabilitation medicine

Zip code

860-0084

Address

6-8-1 Yamamuro Kita-ku,Kumamoto

TEL

096-345-8111

Email

juryopt.teraguchi3175@gamil.com


Public contact

Name of contact person

1st name Takuma
Middle name
Last name Teraguchi

Organization

Medical Corporation Juryo Kumamoto Kinoh Hospital

Division name

Department of Comprehensive Rehabilitation medicine

Zip code

860-0084

Address

6-8-1 Yamamuro Kita-ku,Kumamoto

TEL

096-345-8111

Homepage URL


Email

juryopt.teraguchi3175@gamil.com


Sponsor or person

Institute

Medical Corporation Juryo Kumamoto Kinoh Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Medical Corporation Juryo Kumamoto Kinoh Hospital

Address

6-8-1 Yamamuro Kita-ku,Kumamoto

Tel

096-345-8111

Email

medlab@juryo.or.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2023 Year 08 Month 31 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 07 Month 21 Day

Date of IRB

2023 Year 07 Month 28 Day

Anticipated trial start date

2023 Year 08 Month 31 Day

Last follow-up date

2027 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2023 Year 08 Month 24 Day

Last modified on

2025 Year 02 Month 22 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000059353

Research Plan
Registered date File name
2024/01/29 様式01-A 研究計画書(介入研究) ★.pdf
Research case data specifications
Registered date File name
2025/02/23 case_teraguchi.xlsx
Research case data
Registered date File name
2025/02/23 ★シングルケースデザインのデータ処理ファイル case3.xlsx

Single case data URL

Value
https://center6.umin.ac.jp/ice/59353